Literature DB >> 21988961

Oxysterol-binding protein (OSBP) enhances replication of intracellular Salmonella and binds the Salmonella SPI-2 effector SseL via its N-terminus.

Sigrid D Auweter1, Hong B Yu, Ellen T Arena, Julian A Guttman, B Brett Finlay.   

Abstract

Effectors translocated into the host cell by Salmonella enterica serovar Typhimurium are critical for bacterial virulence. For many effectors, the mechanisms of their interactions with host pathways are not yet understood. We have recently found an interaction between the SPI-2 effector SseL and oxysterol-binding protein (OSBP). We show here that SseL binds the N-terminus of OSBP and that S. Typhimurium infection results in redistribution of OSBP. We furthermore demonstrate that OSBP is required for efficient replication of intracellular S. Typhimurium. This suggests that S. Typhimurium hijacks OSBP-dependent pathways to benefit its intracellular life-style, possibly by SseL- and OSBP-mediated manipulation of host lipid metabolism.
Copyright © 2011 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21988961     DOI: 10.1016/j.micinf.2011.09.003

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  10 in total

1.  Reconstruction of the temporal signaling network in Salmonella-infected human cells.

Authors:  Gungor Budak; Oyku Eren Ozsoy; Yesim Aydin Son; Tolga Can; Nurcan Tuncbag
Journal:  Front Microbiol       Date:  2015-07-20       Impact factor: 5.640

2.  A model of flux regulation in the cholesterol biosynthesis pathway: Immune mediated graduated flux reduction versus statin-like led stepped flux reduction.

Authors:  Steven Watterson; Maria Luisa Guerriero; Mathieu Blanc; Alexander Mazein; Laurence Loewe; Kevin A Robertson; Holly Gibbs; Guanghou Shui; Markus R Wenk; Jane Hillston; Peter Ghazal
Journal:  Biochimie       Date:  2012-06-01       Impact factor: 4.079

3.  The Salmonella deubiquitinase SseL inhibits selective autophagy of cytosolic aggregates.

Authors:  Francisco S Mesquita; Mair Thomas; Martin Sachse; António J M Santos; Rita Figueira; David W Holden
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

4.  Salmonella Typhimurium manipulates macrophage cholesterol homeostasis through the SseJ-mediated suppression of the host cholesterol transport protein ABCA1.

Authors:  Adam R Greene; Katherine A Owen; James E Casanova
Journal:  Cell Microbiol       Date:  2021-04-22       Impact factor: 4.115

Review 5.  Ubiquitination as an efficient molecular strategy employed in salmonella infection.

Authors:  Lakshmi A Narayanan; Mariola J Edelmann
Journal:  Front Immunol       Date:  2014-11-25       Impact factor: 7.561

Review 6.  Targeting host lipid flows: Exploring new antiviral and antibiotic strategies.

Authors:  Alberto Fernández-Oliva; Paula Ortega-González; Cristina Risco
Journal:  Cell Microbiol       Date:  2019-01-17       Impact factor: 3.715

7.  Lack of effect of the Salmonella deubiquitinase SseL on the NF-κB pathway.

Authors:  Francisco S Mesquita; David W Holden; Nathalie Rolhion
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

8.  Global mapping of Salmonella enterica-host protein-protein interactions during infection.

Authors:  Philipp Walch; Joel Selkrig; Leigh A Knodler; Mandy Rettel; Frank Stein; Keith Fernandez; Cristina Viéitez; Clément M Potel; Karoline Scholzen; Matthias Geyer; Klemens Rottner; Olivia Steele-Mortimer; Mikhail M Savitski; David W Holden; Athanasios Typas
Journal:  Cell Host Microbe       Date:  2021-07-07       Impact factor: 31.316

9.  Oxysterols and their cellular effectors.

Authors:  Vesa M Olkkonen; Olivier Béaslas; Eija Nissilä
Journal:  Biomolecules       Date:  2012-02-15

10.  The Molecular Basis for Ubiquitin and Ubiquitin-like Specificities in Bacterial Effector Proteases.

Authors:  Jonathan N Pruneda; Charlotte H Durkin; Paul P Geurink; Huib Ovaa; Balaji Santhanam; David W Holden; David Komander
Journal:  Mol Cell       Date:  2016-07-14       Impact factor: 17.970

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.